These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 13619675)

  • 1. Antagonism between harmaline and longacting monoamine oxidase inhibitors concerning the effect on 5-hydroxytryptamine and norepinephrine metabolism in the brain.
    PLETSCHER A; BESENDORF H
    Experientia; 1959 Jan; 15(1):25-6. PubMed ID: 13619675
    [No Abstract]   [Full Text] [Related]  

  • 2. Some relationships between peripheral monoamine oxidase inhibition and brain 5-hydroxytryptamine levels in rats.
    TABACHNICK II; RUBIN AA
    Proc Soc Exp Biol Med; 1959 Jul; 101(3):435-7. PubMed ID: 13675270
    [No Abstract]   [Full Text] [Related]  

  • 3. Influence of drugs on the temperature-lowering effect of harmaline.
    Bruinvels J; Sourkes TL
    Eur J Pharmacol; 1968 Aug; 4(1):31-9. PubMed ID: 5692910
    [No Abstract]   [Full Text] [Related]  

  • 4. Selective depletion of noradrenaline and 5-hydroxytryptamine from rat brain and intestine by Rauwolfia alkaloids.
    KARKI NT; PAASONEN MK
    J Neurochem; 1959 Feb; 3(4):352-7. PubMed ID: 13642070
    [No Abstract]   [Full Text] [Related]  

  • 5. Influence of harmaline on the ability of pargyline to alter catecholamine metabolism in rats.
    Fuller RW; Hemrick-Luecke SK; Perry KW
    Biochem Pharmacol; 1981 Jun; 30(11):1295-8. PubMed ID: 7271828
    [No Abstract]   [Full Text] [Related]  

  • 6. Enhanced selectivity of pargyline as an inhibitor of type B monoamine oxidase in harmaline-treated rats.
    Fuller RW; Hemrick SK
    Life Sci; 1978 Mar; 22(12):1083-6. PubMed ID: 642716
    [No Abstract]   [Full Text] [Related]  

  • 7. A new approach to the assessment of the potency of reversible monoamine oxidase inhibitors in vivo, and its application to (+)-amphetamine, p-methoxyamphetamine and harmaline.
    Green AL; El Hait MA
    Biochem Pharmacol; 1980 Oct; 29(20):2781-9. PubMed ID: 6893669
    [No Abstract]   [Full Text] [Related]  

  • 8. An effect of monoamine oxidase inhibitors on brain serotonin of mice in addition to that resulting from inhibition of monoamine oxidase.
    DUBNICK B; LEESON GA; PHILLIPS GE
    J Neurochem; 1962; 9():299-306. PubMed ID: 13888045
    [No Abstract]   [Full Text] [Related]  

  • 9. Activity of monoamine oxidase in relation to the 5-hydroxytrypatamine and norepinephrine content of the rat brain.
    GEY KF; PLETSCHER A
    J Neurochem; 1961 Feb; 6():239-43. PubMed ID: 13704855
    [No Abstract]   [Full Text] [Related]  

  • 10. Lowering of dopamine metabolites in rat brain by harmaline.
    Fuller RW; Hemrick-Luecke SK; Perry KW
    J Pharm Pharmacol; 1981 Apr; 33(4):255-6. PubMed ID: 6115915
    [No Abstract]   [Full Text] [Related]  

  • 11. Solanaceous alkaloids and 5-hydroxytryptamine metabolism.
    Matin MA
    Indian J Med Sci; 1970 Jan; 24(1):13-4. PubMed ID: 5463676
    [No Abstract]   [Full Text] [Related]  

  • 12. Depression of norepinephrine and 5-hydroxytryptamine in the brain by benzoquinolizine derivatives.
    PLETSCHER A; BESENDORF H; GEY KF
    Science; 1959 Mar; 129(3352):844. PubMed ID: 13635024
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Interaction of monoamine oxidase inhibitors with physiological and biochemical mechanisms in brain.
    BRODIE BB; SPECTOR S; SHORE PA
    Ann N Y Acad Sci; 1959 Sep; 80():609-16. PubMed ID: 13804624
    [No Abstract]   [Full Text] [Related]  

  • 14. Biochemical pharmacology of benzo(b)thiophene analogs of harmaline and harmine.
    Bosin TR; Campaigne E; Maickel RP
    Life Sci I; 1972 Jul; 11(14):685-91. PubMed ID: 4656100
    [No Abstract]   [Full Text] [Related]  

  • 15. [INHIBITION OF RAT BRAIN MONOAMINE OXIDASES BY BETA-PHENYLISOPROPYLHYDRAZINE AND HARMALINE: HISTOCHEMICAL STUDY OF THE ACTION OF THESE INHIBITORS AND THEIR ANTAGONISM].
    BOUCHAUD C; COUTEAUX R; GAUTRON J
    C R Hebd Seances Acad Sci; 1965 Jan; 260():348-51. PubMed ID: 14305447
    [No Abstract]   [Full Text] [Related]  

  • 16. [The effect of harmaline on the concentration of noradrenaline and adrenaline in the heart].
    MUSCHOLL E
    Experientia; 1959 Nov; 15():428-9. PubMed ID: 14425482
    [No Abstract]   [Full Text] [Related]  

  • 17. Behavioral effects and brain amine content in rats.
    HESS SM; DOEPFNER W
    Arch Int Pharmacodyn Ther; 1961 Nov; 134():89-99. PubMed ID: 13907003
    [No Abstract]   [Full Text] [Related]  

  • 18. The effect of inhibition of amine oxidase in vivo on administered adrenaline, noradrenaline, tyramine and serotonin.
    CORNE SJ; GRAHAM JD
    J Physiol; 1957 Feb; 135(2):339-49. PubMed ID: 13406744
    [No Abstract]   [Full Text] [Related]  

  • 19. [Effect of iprazid and transamine on monoamine oxidase activity and monoamine content on the brain of dogs and rabbits].
    Kocherga VI; Gotovtseva EP
    Ukr Biokhim Zh; 1967; 39(2):125-9. PubMed ID: 5603055
    [No Abstract]   [Full Text] [Related]  

  • 20. Effect of alpha-alkylated tryptamine derivatives on 5-hydroxytryptamine metabolism in vivo.
    GEY KF; PLETSCHER A
    Br J Pharmacol Chemother; 1962 Aug; 19(1):161-7. PubMed ID: 13898151
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.